Search This Blog

Saturday, September 22, 2018

Spectrum to hold a conference call


Management discusses the new interim Poziotinib data from the MD Anderson Phase 2 non-small cell lung cancer (NSCLC) study on a conference call to be held on September 24 at 4:30 pm.  Weblink: https://edge.media-server.com/m6/p/rkpd2qij
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)